Rovi receives non-binding offers for manufacturing business (updated)

Antin Infrastructure Partners SAS

26/06/2024 13:41

(Adds comments from Rovi in paragraphs 1,2)
       MADRID, June 26 (Reuters) - Rovi  ROVI.MC  has received
non-binding offers for its third-party manufacturing business,
the Spanish pharmaceuticals firm said on Wednesday, without
disclosing the names of the bidders.
    No final decision has been made regarding the potential
sale, Rovi said in a filing to the stock market regulator.
    Investment funds Antin  ANTIN.PA , Cinven, CVC  CVC.AS , KKR
 KKR.N  and Permira have filed bids, newspaper Expansion
reported earlier on Wednesday.
    The five firms filed non-binding bids on June 13 and are now
in the middle of a due diligence process for binding offers, the
newspaper reported.
    Spokespeople for Cinven and KKR declined to comment, while
Antin, CVC and Permira did not immediately respond to requests
for comment.
    Rovi said in March it had hired Lazard  LAZ.N  as an adviser
for a potential sale of a business which has produced COVID-19
vaccines on behalf of Moderna  MRNA.O , among other drugs.
    It is estimated to be worth about 3.5 billion euros ($3.75
billion), Expansion said.
    ($1 = 0.9344 euros)

 (Reporting by Inti Landauro and Joao Manuel Mauricio; editing
by Jason Neely)
 ((Inti.Landauro@thomsonreuters.com;))